-
Perphenazine: D2 Antagonist Research Workflows
2026-09-10
Perphenazine supports two complementary research paths: receptor-informed neuropharmacology assays and host-directed antibacterial studies centered on macrophage ROS, autophagy, and lysosomal activity. This workflow guide connects validated cell-death and opioid-tolerance models with practical controls, formulation guidance, and troubleshooting strategies.
-
DAMGO: Reproducible µ-Opioid Assay Design
2026-09-10
This scenario-based guide shows how DAMGO (SKU B6621) can strengthen µ-opioid receptor signaling research while preventing common misinterpretations in viability, receptor activation, and pain-model assays. It links product specifications with published mechanistic evidence to support practical, reproducible experimental decisions.
-
Methylprednisolone: From Inflammation to Bone Models
2026-09-09
Methylprednisolone is more than an anti-inflammatory reagent: it can create a controlled perturbation for connecting glucocorticoid signaling with osteoclast activity and bone architecture. This article explains how to design and interpret a multiscale assay strategy based on a methylprednisolone-induced osteonecrosis model.
-
Anlotinib: From Angiogenesis Assays to Translation
2026-09-09
An evidence-led perspective on how Anlotinib hydrochloride connects VEGFR2, PDGFRβ, FGFR1, and ERK biology with reproducible angiogenesis assays and translational cancer research. The article separates validated findings from workflow recommendations and interprets a published desmoplastic small round cell tumor case without overstating what a single case can prove.
-
Omeprazole (A2845): Practical Research Guide
2026-09-08
Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research and related antiulcer workflows. This guide covers solvent handling, assay setup, quality control, and interpretation limits; the material is for scientific research only and should not be used for diagnosis, treatment, or clinical decision-making.
-
Candida krusei Phase-Specific Apoptosis in BMECs
2026-09-08
Miao and colleagues show that the yeast and hypha phases of Candida krusei trigger bovine mammary epithelial-cell apoptosis through different dominant routes: mitochondrial signaling for yeast cells and death ligand/receptor signaling for hyphae. The study also identifies TLR2/ERK and JNK/ERK signaling as shared regulatory axes, providing a framework for phase-aware mastitis and MAPK signaling pathway research.
-
Thermal Shift Assays for Bacterial Sensor Ligands
2026-09-07
The reference review explains how thermal shift assays can reveal unknown ligands for bacterial receptors, transcriptional regulators, and other sensor proteins by monitoring ligand-dependent changes in protein stability. Its main contribution is a practical framework for improving reliability through soluble ligand-binding domains, pH screening, control of false results, and orthogonal confirmation with direct binding methods such as isothermal titration calorimetry.
-
Balsalazide disodium Research Workflows
2026-09-05
Build colon-focused inflammation studies around bacterial azoreduction, 5-ASA release, and practical assay controls. This workflow distinguishes direct compound exposure from microbiota-dependent activation, while extending naturally into radiolabeling and inflammatory bowel disease models.
-
Axitinib (AG 013736) Assay Workflow
2026-09-05
Build more informative angiogenesis and cancer-response experiments with Axitinib, a potent VEGFR1/2/3 inhibitor suited to pathway, endothelial, and xenograft-oriented workflows. The key advantage is not only nanomolar pathway control, but also the ability to separate reduced proliferation from genuine cell killing when interpreting drug-response data.
-
Tetramethylrhodamine ethyl ester perchlorate Workflow
2026-09-04
Tetramethylrhodamine ethyl ester perchlorate provides a live-cell readout of mitochondrial membrane potential that complements, rather than replaces, ROS measurements. This practical workflow shows how to apply TMRE in microscopy, flow cytometry, and toxin-induced mitochondrial dysfunction studies while controlling the variables that most often distort fluorescence.
-
Wnt-C59: A PORCN Inhibitor for Wnt Assays
2026-09-04
Wnt-C59 provides an upstream way to test whether Wnt ligand secretion drives β-catenin activity, exosome function, or cancer-cell behavior. This practical guide connects reporter assays, lithium-conditioned BMSC exosomes, and cholangiocarcinoma models with actionable dosing, controls, and troubleshooting steps.
-
Procainamide Hydrochloride Assay Guide
2026-09-03
A scenario-based guide to using Procainamide Hydrochloride in viability, proliferation, cytotoxicity, and cardiac electrophysiology research. It explains how SKU B4798 supports solvent compatibility, concentration selection, interpretation of MTT results, and reproducible reagent qualification.
-
AG-490: A Mechanistic Guide to JAK2/STAT6 Assays
2026-09-03
AG-490 and Tyrphostin B42 provide a useful pharmacological lens for testing exosome-driven JAK2/STAT6 signaling. This guide translates hepatocellular carcinoma findings into better-controlled macrophage, cancer research, and cytokine-response assays.
-
Vitamin C Workflows for Organoid and Cancer Research
2026-09-02
Use ascorbic acid as a controlled host-state perturbation in HEV organoids and as a concentration-defined anticancer assay reagent. This workflow separates antiviral interpretation from cytotoxicity while using fresh, quality-controlled Vitamin C to improve assay reproducibility.
-
CCR5-Positive Extracellular Vesicles in Rheumatoid Arthritis
2026-09-02
A 2025 study identifies CCR5-bearing extracellular vesicles released by rheumatoid arthritis synovial fibroblasts as active mediators of cartilage destruction, bone erosion, and NF-κB signaling. Its combination of CCR5-deficient vesicles, Maraviroc-loaded vesicles, human cartilage-cell assays, and adjuvant-induced arthritis provides a mechanistic framework for evaluating CCR5-targeted intervention in rheumatoid arthritis.